Kentucky HB 52: AN ACT relating to controlled substances. Amend 218A.010 to provide definitions for “fentanyl” and “fentanyl derivative”; amend KRS 218A.020 to allow the Office of Drug Control Policy to request that the Cabinet for Health and Family Services schedule fentanyl analogues not approved for human use by the United States Food and Drug Administration; amend KRS 218A.050 to include fentanyl analogues not approved for human use by the Food and Drug Administration as a Schedule I controlled substance; amend KRS 218A.142 to create the offense of aggravated fentanyl trafficking; amend KRS 218A.1412 to increase the penalties for trafficking in fentanyl.

Status: To Judiciary (H) (as of 2017-01-03)

State: Kentucky · Session: 2017RS · Bill: HB 52

View Kentucky HB 52 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.